Trial Information

Summary: A multi-center, open-labeled study of the safety, efficacy, and pharmacokinetics of lupiprostone in pediatric patients with constipation.

The purpose of this is to see if lubiprostone is safe and effective for use in children. If your child takes part, your child will be one of 120 subjects in the study. This study will involve six study visits including five office visits and one telephone call. Your child’s total participation in the study will last about 8 weeks.

Study inclusion / exclusion criteria

  • 17 years of age or younger
  • Weighs at least 26 1/2 pounds (12 kg) and is capable of swallowing capsules
  • Has been diagnosed with constipation

For more information,

Contact:

Nancy Stinnett , Coordinator
Minnesota Gastroenterology
15700 37th Ave.
North Plymouth, MN
Telephone: 612-870-5570
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:29 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA